Here, downregulation of ARG2 not only enhanced type II collagen and aggrecan levels, but also inhibited the catabolism of ECM by downregulating matrix-degrading enzymes, suggesting that siRNA-ARG2 may have a protective effect on IDD (Figure 3). Here, ACAN is linked to intervertebral disk degenerative disorder.